MicroRNAs: Turning the Tide in Testicular Cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31230742.
- Also identified by DOI 10.1016/j.eururo.2019.06.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.
Medical subject headings
- MicroRNAs
- Neoplasms, Germ Cell and Embryonal
- Patient Care Management
- Testicular Neoplasms